期刊文献+

过氧化物酶体增殖物激活受体γ2基因Pro12Ala多态性与宁夏回、汉族原发性高血压的关系 被引量:7

Relationship between the polymorphism of peroxisome proliferatorsactivated receptor 2 gene Pro12Ala and essential hypertension in Hui and Han nationality in Ningxia Province
原文传递
导出
摘要 目的:探讨宁夏地区回、汉族原发性高血压(EH)人群与过氧化物酶体增殖物激活受体γ2(PPARγ2)基因Pro12Ala多态性的关系及其相关危险因素。方法:应用病例-对照研究方法,选取宁夏回族EH患者146例(回EH组)、血压正常者112例(回NT组),汉族EH患者163例(汉EH组)、血压正常者178例(汉NT组),采用多聚酶链式反应结合限制性片段长度多态性技术进行PPARγ2基因Pro12Ala多态性的检测,分析此多态位点不同基因型及等位基因频率在宁夏地区回、汉族人群中的分布。结果:(1)回族:回EH组PP、PA和AA基因型频率为85.62%、13.70%、0.68%,回NT组中分别为90.18%、9.82%、0(回NT组中未发现AA型),差异无统计学意义(P>0.05);P与A等位基因频率在回EH组中为92.47%和7.53%,回NT组中为95.09%和4.91%,差异亦无统计学意义(P>0.05)。(2)汉族:汉EH组PP、PA和AA基因型频率为84.05%、15.34%、0.61%,汉NT组为88.76%、11.24%、0(汉NT组中亦未发现AA型);P与A等位基因频率在汉EH组中为91.72%和8.28%,在汉NT组中为94.38%和5.62%,差异无统计学意义(P>0.05)。(3)二项逐步logistic回归:回、汉族NT组间基因型、等位基因频率差异无统计学意义(P>0.05);汉族、体质指数(BMI)、血糖(GLU)、尿酸(UA)、总胆固醇(TC)、低密度脂蛋白(LDL-C)为EH的独立危险因素,高密度脂蛋白(HDL-C)为保护因素。结论:PPARγ2基因Pro12Ala多态性与宁夏地区回、汉族EH人群发病无相关性;此多态性在宁夏回、汉族人群间无种族差异性。 Objective:To investigate the association between the polymorphism of peroxisome proliferators-activated receptor 2 gene Pro12 Ala and EH in Hui and Han nationality in Ningxia Province and its related risk factors.Method:In the case-control study,we selected 146 cases of Ningxia Hui EH patients(EH group),112 cases with normal blood pressures(NT group),163 cases of Han EH patients(EH group),and 178 cases with normal blood pressures(NT group).Polymerase chain reaction restriction fragment length polymorphism technique was used to detect PPAR gamma 2 gene Pro12 Ala polymorphism.We analyzed the distribution of polymorphism of different genotypes and allele frequencies in Ningxia Hui and Han population.Result:(1) Hui nationality:In EH group,PP,PA and AA genotype frequency was 85.62%,13.70%,0.68%,respectively and was 90.18%,9.82%,0(type AA was not found)in group NT,there was no significant difference(P〉0.05).P and A allele frequencies in EH group were 92.47%and 7.53%,and were 95.09%and 4.91%in NT group,there was no significant difference(P〉0.05).(2) Han nationality:In EH group,PP,PA and AA genotype frequency were84.05%,15.34%,0.61%,and were 88.76%,11.24%,0(type AA was not found)in group NT.P and A allele frequency in EH group were 91.72% and 8.28%,and were 94.38% and 5.62%in NT group.there was no statistical difference meaning(P〉0.05).(3)Binary step wise logistic regression analysis:There were no allele frequency or genotype differences between Hui and Han groups(P〉0.05).Body mass index(BMI),blood glucose(GLU),uric acid(UA),total cholesterol(TC),low density lipoprotein(LDL-C)were the independent risk factors of EH.High density lipoprotein(HDL-C)was a protective factor.Conclusion:The Pro12 Ala polymorphism of PPAR gamma 2 gene is not related to the incidence of primary hypertension in Hui and Han nationalities in Ningxia.There is no racial difference between the Hui and the Han population in this area.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2018年第1期47-51,共5页 Journal of Clinical Cardiology
关键词 过氧化物酶体增殖物激活受体γ2 原发性高血压 基因多态性 汉族 回族 PPARγ essential hypertension gene polymorphism Han nationality Hui nationality
  • 相关文献

参考文献6

二级参考文献62

  • 1Vander Josédas Neves,Tiago Fernandes,Fernanda Roberta Roque,Ursula Paula RenóSoci,Stéphano Freitas Soares Melo,Edilamar Menezes de Oliveira.Exercise training in hypertension:Role of microRNAs[J].World Journal of Cardiology,2014,6(8):713-727. 被引量:9
  • 2姚伟东,柏霞,于安中,王焕勤.颈动脉粥样斑块及内膜厚度与冠状动脉病变的相关性研究[J].中国心血管杂志,2005,10(2):129-130. 被引量:9
  • 3李利平,董砚虎,丁明,付方明,高维国,董超.过氧化物酶体增殖物激活受体γC161T点突变与2型糖尿病合并冠心病的相关性[J].中华糖尿病杂志(1006-6187),2005,13(3):213-215. 被引量:5
  • 4Yen C J,et a1.Molecular scanning of the human pemxisome pmlifer-ator activated receptor gamma(hPPAR gamma)gene in diabetic Caucasians:identification of a Prol2Ala PPAR gamma2missense mutation[J].Biochem Biophys Res Commun,1997,241(2):270—274.
  • 5ZhouX,Chen J,Xu W.et al.Association between C1431T polymorphism in peroxisome proliferator-activated receptor-γgene and coronary artery disease in Chinese Han population.Mol Biol Rep.2011Feb;39(2):1863-8.
  • 6AshokKumar M,Veera Subhashini NG,Kanthimathi S,et al.Associations for lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in an Indian population.Arch Med Res.2010Jan;41(1):19-25.e1.
  • 7Aydogan HY,Kü?ükhüseyin O,Tekeli A,Isbir T.et al.Associations of Receptor for Advanced Glycation End Products-374T/A and Gly82Ser and Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala Polymorphisms in Turkish Coronary Artery Disease Patient.Genet Test Mol Biomarkers.2011Aug23.
  • 8Rhee EJ,Oh KW,Lee WY,et al.Effects of two common polymorphismsof peroxisome proliferator-activated receptor-gamma gene onmetabolic syndrome[J].Arch Med Res.2006,37(1):86-94.
  • 9Cresci S,Wu J,Province MA,Spertus JA,et al.Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type2diabetes in the bypass angioplasty revascularization investigation2diabetes trial.Circulation.2011Sep27;124(13):1426-34.
  • 10Giaginis C,Klonaris C,Katsargyris A,et al.Correlation of Peroxisome Proliferator-Activated Receptor-gamma(PPAR-gamma)and Retinoid X Receptor-alpha(RXR-alpha)expression with clinical risk factors in patients with advanced carotid atherosclerosis.Med Sci Monit.2011Jul;17(7):CR381-91.

共引文献28

同被引文献46

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部